Respiratory Decade is inviting you to important Respiratory events:
To celebrate the 50th Anniversary since the Discovery of Alpha-1-Antitrypsin (AAT) LOVEXAIR organized two key events: The International Scientific Conference related to AAT Deficiency and the 4th International Patient Congress, which will be celebrated from 11-13 April, in the Hotel Hilton Diagonal Mar, Barcelona, 2013. This year being the Year for Rare Disease in Spain.
To celebrate the 50th Anniversary since the Discovery of Alpha-1-Antitrypsin (AAT) LOVEXAIR organized two key events: The International Scientific Conference related to AAT Deficiency and the 4th International Patient Congress, which will be celebrated from 11-13 April, in the Hotel Hilton Diagonal Mar, Barcelona, 2013. This year being the Year for Rare Disease in Spain.
Barcelona will be the world capital in liver and lung disease
research and specialized healthcare for this momentous occasion to
create awareness about Alpha-1-Antitrypsin, in both research and
patient community empowerment. Sten Eriksson, one of the discoverers of AAT Deficiency, will also be attending this important event.
For
this special occasion we will welcome more than 200 delegates from
around the world, with representatives from patient and scientific
communities, particularly America and Europe, as well as leading
scientific experts in this chronic rare disease.
The 4th International Patient Congress, 12-13 April
will bring together patients and their family members and in parallel,
an International Scientific Conference on Alpha-1 Research, 11-12 April,
simultaneously attended by healthcare professionals and leading
scientists in Alpha-1 research and industry with expertise in advanced
therapies.
The
main focus of this event is to create heightened awareness about
Alpha-1-Antitrypsin deficiency; bring together representatives from
Alpha-1 organizations from around the world and to promote debate and
dialogue about the impact and the situation in each country; identify
unmet needs; learn the latest developments in research in advanced and
innovative therapies, and bring together both researchers and patients
to improve and support building a cure for Alpha-1 in the future: "It's
time for a cure".
The
goal is also to empower patients and their organization leaders, build
on sharing best- practices and skill-sets and form an international
working group to move forward in key areas which are considered
important, across the community as a result of participating in this
event.
No comments:
Post a Comment